US FDA Classifies Aurobindo Pharma's Eugia Unit-III Inspection as Official Action Indicated
Aurobindo Pharma said the US FDA has classified its inspection of Eugia Unit-III in Telangana as Official Action Indicated, while reaffirming its commitment to maintaining global quality manufacturing standards.
Official Action Indicated | 16/06/2026 | By News Bureau | 108
US FDA Places Sun Pharma's Baska Facility Under 'Official Action Indicated' After Inspection
Sun Pharmaceutical Industries Ltd said the U.S. Food and Drug Administration (FDA) has assigned an “Official Action Indicated” (OAI) status to its Baska manufacturing facility following a recent regulatory inspection.
Official Action Indicated | 18/12/2025 | By Darshana | 327
US FDA Classifies Lupin's Pithampur Unit-2 as Official Action Indicated
The US Food and Drug Administration (FDA) has concluded its inspection of Lupin’s Pithampur Unit-2 manufacturing facility, issuing a Form 483 with four observations.
Official Action Indicated | 04/10/2025 | By Dineshwori | 616
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.
Official Action Indicated | 25/08/2023 | By Manvi | 1681
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy